LU82369A1 - Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote,et utilisation pour traiter des desordres renaux - Google Patents

Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote,et utilisation pour traiter des desordres renaux Download PDF

Info

Publication number
LU82369A1
LU82369A1 LU82369A LU82369A LU82369A1 LU 82369 A1 LU82369 A1 LU 82369A1 LU 82369 A LU82369 A LU 82369A LU 82369 A LU82369 A LU 82369A LU 82369 A1 LU82369 A1 LU 82369A1
Authority
LU
Luxembourg
Prior art keywords
essential
amino acids
semi
free
essential amino
Prior art date
Application number
LU82369A
Other languages
English (en)
French (fr)
Inventor
M Walser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of LU82369A1 publication Critical patent/LU82369A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU82369A 1979-04-18 1980-04-17 Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote,et utilisation pour traiter des desordres renaux LU82369A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3127479 1979-04-18
US06/031,274 US4296127A (en) 1979-04-18 1979-04-18 Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof

Publications (1)

Publication Number Publication Date
LU82369A1 true LU82369A1 (fr) 1980-07-31

Family

ID=21858554

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82369A LU82369A1 (fr) 1979-04-18 1980-04-17 Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote,et utilisation pour traiter des desordres renaux

Country Status (16)

Country Link
US (1) US4296127A (xx)
JP (1) JPS6024094B2 (xx)
BE (1) BE882833A (xx)
CA (1) CA1139768A (xx)
DE (1) DE3015076A1 (xx)
DK (1) DK159147C (xx)
ES (1) ES8102804A1 (xx)
FI (1) FI70206C (xx)
FR (1) FR2454434A1 (xx)
GB (1) GB2048867B (xx)
IE (1) IE49586B1 (xx)
IT (1) IT1141482B (xx)
LU (1) LU82369A1 (xx)
NL (1) NL191583C (xx)
NO (1) NO155239C (xx)
SE (1) SE460902B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168425A4 (en) * 1984-01-16 1989-03-09 Baxter Travenol Lab PARENTERAL NUTRITION WITH MEDIUM AND LONG CHAIN TRIGLYCERIDES.
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
DE3936319C3 (de) * 1989-11-01 1997-05-07 Bartz Volker Phosphatbinder zur oralen Verabreichung
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20070141181A1 (en) * 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
EP1056464A1 (en) 1998-02-27 2000-12-06 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US8680329B2 (en) * 2010-10-13 2014-03-25 Tianjin Tiancheng Pharmaceutical Co., Ltd. (China) Process for preparation of α-ketoglutaric acid
US8754256B2 (en) * 2010-10-13 2014-06-17 Tianjin Tiancheng Pharmaceutical Co., Ltd. (China) Process for preparation of L-Arginine α-ketoglutarate 1:1 and 2:1
US20140187815A1 (en) * 2012-12-28 2014-07-03 Guoji Zhang Process for preparation of l-arginine alpha-ketoglutarate 1:1 and 2:1
WO2020208050A1 (en) * 2019-04-11 2020-10-15 Merck Patent Gmbh Cell culture media comprising keto acids

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2457820A (en) * 1945-12-27 1949-01-04 Merck & Co Inc Amino acid solution and process for preparing the same
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
US3764703A (en) * 1969-11-07 1973-10-09 Astra Ab Amino acid mixture for use in treatment of uremic conditions
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
US4100161A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Promotion of protein synthesis and suppression of urea formation in the body by keto analogs of essential amino acids
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
FR2315916A2 (fr) * 1976-03-23 1977-01-28 Univ Johns Hopkins Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
DE2759133A1 (de) * 1976-12-31 1978-07-13 Carmelo Prof Giordano Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Also Published As

Publication number Publication date
FI70206C (fi) 1986-09-15
GB2048867B (en) 1983-03-16
SE460902B (sv) 1989-12-04
DK159147C (da) 1991-02-11
IT1141482B (it) 1986-10-01
JPS5653641A (en) 1981-05-13
DK163180A (da) 1980-10-19
JPS6024094B2 (ja) 1985-06-11
FI801225A (fi) 1980-10-19
NO155239C (no) 1987-03-04
ES490649A0 (es) 1981-02-16
DK159147B (da) 1990-09-10
IE49586B1 (en) 1985-10-30
DE3015076C2 (xx) 1988-01-21
FI70206B (fi) 1986-02-28
NL191583C (nl) 1995-10-03
US4296127A (en) 1981-10-20
NO801119L (no) 1980-10-20
BE882833A (fr) 1980-08-18
IT8021498A0 (it) 1980-04-18
ES8102804A1 (es) 1981-02-16
FR2454434B1 (xx) 1984-02-24
NO155239B (no) 1986-11-24
SE8002900L (sv) 1980-12-12
IE800781L (en) 1980-10-19
CA1139768A (en) 1983-01-18
GB2048867A (en) 1980-12-17
NL8002297A (nl) 1980-10-21
DE3015076A1 (de) 1980-10-30
NL191583B (nl) 1995-06-01
FR2454434A1 (fr) 1980-11-14

Similar Documents

Publication Publication Date Title
LU82369A1 (fr) Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote,et utilisation pour traiter des desordres renaux
US4352814A (en) Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs
EP2349217A1 (fr) Nouvelle composition à base d'acide gamma-hydroxybutyrique
EP0399903B1 (fr) Nouvelles compositions à base d'imipramine
FR2602141A1 (fr) Composition pharmaceutique a activite analgesique contenant de l'ibuprofene comme principe actif
FR2482456A1 (fr) Composition en gel, anti-inflammatoire et analgesique, a base de ketoprofene et/ou de flurbiprofene
JP2018505191A (ja) 腎不全患者治療のためのカルボン酸混合物
JP2007514728A (ja) プレガバリン組成物
FR2618331A1 (fr) Compositions pharmaceutiques utiles pour le traitement de l'uremie
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
FR2480603A1 (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
JPH0116809B2 (xx)
LU87102A1 (fr) Combinaison iyophilisee ou precipitee de zwitterbn de cephalosporine et de sel
EP0099799B1 (fr) Nouveaux sels d'amino- (et imino-) acides alpha, omega-sulfoniques N-substitués, vecteurs cationiques de haute pénétration cellulaire, procédé d'obtention
JPH03204814A (ja) 腎不全用経口アミノ酸製剤
CA2064999A1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et utilisation comme medicaments
JPWO2019246256A5 (xx)
EP2736507B1 (en) Basic alpha lipoic acid solution and its uses
FR2574662A1 (fr) Procede de preparation d'un nouveau complexe d'hemine et produit ainsi obtenu et medicaments le contenant
CA2022447A1 (fr) Forme galenique orale ameliorant la biodisponibilite
LU83081A1 (fr) Compositions antitumeurs
BE887220A (fr) Compositions antitumeurs
EP1319663A1 (fr) Sels de lithium d'acides folique, folinique et glutamique, antidépresseurs
WO2008107569A2 (fr) Complexes d'inclusion de cysteine, leur preparation et les compositions les contenant
CA3143343A1 (en) Stimulant composition and process for making same